PE34297A1 - SPECIFIC LEAGUES OF NEUROPEPTIDE Y1 - Google Patents

SPECIFIC LEAGUES OF NEUROPEPTIDE Y1

Info

Publication number
PE34297A1
PE34297A1 PE1996000325A PE00032596A PE34297A1 PE 34297 A1 PE34297 A1 PE 34297A1 PE 1996000325 A PE1996000325 A PE 1996000325A PE 00032596 A PE00032596 A PE 00032596A PE 34297 A1 PE34297 A1 PE 34297A1
Authority
PE
Peru
Prior art keywords
alkyl
hydrogen
hydroxyl
neuropeptide
alcoxy
Prior art date
Application number
PE1996000325A
Other languages
Spanish (es)
Inventor
John M Peterson
Charles A Blum
Guolin Cai
Alan Hutchison
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/014472 external-priority patent/WO1996014307A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE34297A1 publication Critical patent/PE34297A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA GENERAL (I), PREFERENTEMENTE TAL COMO LA FORMULA (II), EN DONDE: Ar ES FENILO, 2-, 3- O 4-PIRIDILO, ENTRE OTROS GRUPOS ARILO, LOS CUALES SE ENCUENTRAN OPCIONALMENTE CON 1 o 2 SUSTITUCIONES DE RADICALES HIDROXILO O HALOGENO, ENTRE OTROS; B ES OXIGENO, N(R5) O C(R5)(R6), ENTRE OTROS; n ES 1; 2 o 3; m ES 2; 3 o 4; R1 Y R2 SON HIDROGENO O ALQUILO C1-C6; R3 Y R4 SON HIDROGENO, ALQUILO C1-C6 O ALCOXI C1-C6; R5 ES ALQUILO C1-C6 O FENILO, ENTRE OTROS; A Y R6 SON HIDROGENO, HIDROXILO, AMINO, ALQUILO C1-C6 O FENILO, ENTRE OTROS; W, X, Y Y T SON HIDROGENO, HIDROXILO, HALOGENO, ALQUILO C1-C6 O ALCOXI C1-C6; R9 ES PREFERENTEMENTE HIDROGENO O METILO. ESTOS COMPUESTOS ACTUAN INHIBIENDO LOS RECEPTORES DEL NEUROPEPTIDO HUMANO Y1 (NPY1), SIENDO USADOS EN EL TRATAMIENTO DE CONDICIONES TALES COMO LA OBESIDAD, LA BULIMIA, ENTRE OTRASIT REFERS TO COMPOUNDS OF GENERAL FORMULA (I), PREFERABLY SUCH AS FORMULA (II), WHERE: Ar IS FENILO, 2-, 3- OR 4-PIRIDILO, AMONG OTHER ARILO GROUPS, WHICH ARE OPTIONALLY WITH 1 o 2 SUBSTITUTIONS FOR HYDROXYL OR HALOGEN RADICALS, AMONG OTHERS; B IS OXYGEN, N (R5) O C (R5) (R6), AMONG OTHERS; n IS 1; 2 or 3; m ES 2; 3 or 4; R1 AND R2 ARE HYDROGEN OR C1-C6 ALKYL; R3 AND R4 ARE HYDROGEN, C1-C6 ALKYL OR C1-C6 ALCOXY; R5 IS C1-C6 ALKYL OR PHENYL, AMONG OTHERS; A AND R6 ARE HYDROGEN, HYDROXYL, AMINO, C1-C6 ALKYL OR PHENYL, AMONG OTHERS; W, X, Y and T ARE HYDROGEN, HYDROXYL, HALOGEN, C1-C6-ALKYL OR C1-C6-ALCOXY; R9 IS PREFERABLY HYDROGEN OR METHYL. THESE COMPOUNDS ACT BY INHIBITING THE RECEPTORS OF THE HUMAN NEUROPEPTIDE Y1 (NPY1), BEING USED IN THE TREATMENT OF CONDITIONS SUCH AS OBESITY, BULIMIA, AMONG OTHERS

PE1996000325A 1995-06-07 1996-05-08 SPECIFIC LEAGUES OF NEUROPEPTIDE Y1 PE34297A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47838395A 1995-06-07 1995-06-07
US48497495A 1995-06-07 1995-06-07
PCT/US1995/014472 WO1996014307A1 (en) 1994-11-07 1995-11-07 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Publications (1)

Publication Number Publication Date
PE34297A1 true PE34297A1 (en) 1997-09-24

Family

ID=27045885

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000325A PE34297A1 (en) 1995-06-07 1996-05-08 SPECIFIC LEAGUES OF NEUROPEPTIDE Y1

Country Status (11)

Country Link
EP (1) EP0833823A1 (en)
JP (1) JPH10507203A (en)
AU (1) AU5578796A (en)
BR (1) BR9609334A (en)
CA (1) CA2220958A1 (en)
CO (1) CO4700426A1 (en)
IL (1) IL117997A0 (en)
MA (1) MA23860A1 (en)
PE (1) PE34297A1 (en)
TR (1) TR199600382A2 (en)
WO (1) WO1996040660A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260982A1 (en) * 1996-07-23 1998-01-29 Neurogen Corporation Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
EP0915859B1 (en) * 1996-07-23 2003-01-02 Neurogen Corporation Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
JP2000515527A (en) * 1996-07-23 2000-11-21 ニューロジェン・コーポレーション Specific amide- and amino-substituted benzylamine derivatives; a new class of neuropeptide Y1-specific ligands
US6048900A (en) 1998-02-13 2000-04-11 Bayer Corporation Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
EP0910565A1 (en) * 1997-02-14 1999-04-28 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
US6245817B1 (en) 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
EP0927166A1 (en) * 1997-02-14 1999-07-07 Bayer Corporation Amides as npy5 receptor antagonists
US6420130B1 (en) 1998-12-14 2002-07-16 Aurora Biosciences Corporation Optical molecular sensors for cytochrome P450 activity
ATE240310T1 (en) * 1998-12-14 2003-05-15 Vertex Pharma San Diego Llc OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P-450 ACTIVITY
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
NZ546887A (en) 2003-11-03 2009-04-30 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
EP1713780B1 (en) 2004-02-05 2012-01-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
US7674811B2 (en) 2006-03-14 2010-03-09 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
KR20090115951A (en) 2007-03-01 2009-11-10 프로비오드룩 아게 New use of glutaminyl cyclase inhibitors
DK2142514T3 (en) 2007-04-18 2015-03-23 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
AU2010294214B2 (en) 2009-09-11 2015-05-07 Vivoryon Therapeutics N.V. Heterocylcic derivatives as inhibitors of glutaminyl cyclase
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
BR112012022478B1 (en) 2010-03-10 2021-09-21 Probiodrug Ag HETEROCYCLIC GLUTAMINYL CYCLASE INHIBITORS (QC, EC 2.3.2.5), THEIR PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITION
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
PL3461819T3 (en) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitors of glutaminyl cyclase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
DK0395312T3 (en) * 1989-04-22 1999-06-23 Wyeth John & Brother Ltd piperazine

Also Published As

Publication number Publication date
MX9709980A (en) 1998-03-29
CO4700426A1 (en) 1998-12-29
EP0833823A1 (en) 1998-04-08
JPH10507203A (en) 1998-07-14
TR199600382A2 (en) 1996-12-21
IL117997A0 (en) 1996-10-31
WO1996040660A1 (en) 1996-12-19
CA2220958A1 (en) 1996-12-19
BR9609334A (en) 1999-05-25
MA23860A1 (en) 1996-12-31
AU5578796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
PE34297A1 (en) SPECIFIC LEAGUES OF NEUROPEPTIDE Y1
AR008384A1 (en) TOPIC COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS, USE OF THE COMPOUND FOR THE PREPARATION OF A NON-THERAPEUTIC MEDICINAL PRODUCT AND METHOD FOR SKIN POLISHING AND HAIR SOFTENING.
AR006867A1 (en) TOPIC SKIN COMPOSITION INCLUDING AN OXA-DIÁCIDO COMPOUND, ITS USE TO PREPARE A MEDICATION TO TREAT SKIN CONDITIONS AND NON-THERAPEUTIC COSMETIC METHODS FOR SKIN POLISHING AND TO SOFTEN THE APPLIED HAIR.
DE69504300D1 (en) GEM BIT-SUBSTITUTED AZACYCLIC TACHYKININ ANTAGONISTS
DK0736039T3 (en) Compounds with growth hormone-releasing properties
DK0687268T3 (en) Spiroazacyclic derivatives as substance P antagonists
MY135841A (en) Novel benzodioxoles
PE50994A1 (en) DERIVATIVE OF 1.5 BENZODIAZEPINA
PE20030703A1 (en) 17B-HYDROXIESTEROID DEHYDROGENASE TYPE 3 INHIBITORS
ATE172723T1 (en) TRYPTAMINE ANALOGAS, THEIR PREPARATION AND USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTS
PE20030471A1 (en) IMIDAZOPIRIDIN COMPOUND AS 5-HT4 RECEIVER MODULATORS
SE9702564D0 (en) New compounds
NZ528997A (en) Sulfonamides
HUT62264A (en) Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient
ZA902633B (en) New sulphonamides derived from benzo-cyclic or benzo heterocyclic acids,their preparation and their application in therapy
ID26622A (en) 2-BENZYLAMINO-2-PHENYL-ACETAMIDE REPLACEMENT COMPOUNDS
NO983178L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
PE20040750A1 (en) DERIVATIVES OF N- (1-ACETYLPIPERIDIN-4-IL) -4-BENZIDRIL-2-ISOPROPILPIPERAZIN-1-CARBOXAMIDE AS INHIBITORS OF 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3
PE25998A1 (en) DERIVATIVES OF OCTAHIDRO-PIRROLO (1,2-a) -PIRAZINA 2,7-SUBSTITUTED
DE69307895D1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE
DK0660822T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotics
NO973340L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
AR009666A1 (en) CARBOXAMIDE DERIVED COMPOUNDS CYCLICAL SUBSTITUTED FOR CARBOXI, PHARMACEUTICAL COMPOSITION, USES IN THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS FOR ASTHMA, TOS AND BRONCHITIS AND PREPARATION PROCEDURE
CO4410157A1 (en) A PLANT GROWTH REGULATORY MIX THAT INCLUDES 1,1-DIMETHYLPIPERIDINE CHLORIDE (MEPIQUAT) AND A DERIVATIVE OF CYCLOPROPYLMALONANILIC ACID
ATE203533T1 (en) INDOLE DERIVATIVES AS PRODRUGS OF ß5-HT1-LIKES RECEPTOR AGONISTS

Legal Events

Date Code Title Description
FD Application declared void or lapsed